These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36306113)

  • 1. Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms.
    Ghasemi R; Lotfali E; Rezaei K; Madinehzad SA; Tafti MF; Aliabadi N; Kouhsari E; Fattahi M
    Braz J Microbiol; 2022 Dec; 53(4):1761-1779. PubMed ID: 36306113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of cryptic species and clades of
    Francisco EC; Ribeiro FC; Almeida Junior JN; Pedoni DB; da Matta DA; Dolande M; Melo ASA; Lima RF; Aquino VR; Corzo-León DE; Zurita J; Cortes JA; Nucci M; Colombo AL
    Microbiol Spectr; 2023 Sep; 11(5):e0511522. PubMed ID: 37698428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-series of bloodstream infections caused by the Meyerozyma guilliermondii species complex at a reference center of oncology in Brazil.
    Chaves ALS; Trilles L; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Coelho RA; Martins IS; Almeida-Paes R
    Med Mycol; 2021 Mar; 59(3):235-243. PubMed ID: 32497174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of Meyerozyma guilliermondii from blood cultures and surveillance samples in a university hospital in Northeast Turkey: A ten-year survey.
    Cebeci Güler N; Tosun I; Aydin F
    J Mycol Med; 2017 Dec; 27(4):506-513. PubMed ID: 28843335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-azole-resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11.
    Moreau J; Noël T; Point K; Tewes F; Deroche L; Clarhaut J; Fitton-Ouhabi V; Perraud E; Marchand S; Buyck JM; Brunet K
    Mycoses; 2024 Mar; 67(3):e13704. PubMed ID: 38429226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Antifungal Susceptibility of
    Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
    Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
    Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts.
    Stavrou AA; Pérez-Hansen A; Lackner M; Lass-Flörl C; Boekhout T
    Med Mycol; 2020 Oct; 58(7):987-995. PubMed ID: 32043147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Genomes of Four
    De Marco L; Epis S; Capone A; Martin E; Bozic J; Crotti E; Ricci I; Sassera D
    G3 (Bethesda); 2018 Mar; 8(3):755-759. PubMed ID: 29311113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts.
    Montoya AM; Luna-Rodríguez CE; Gracia-Robles G; Rojas OC; González GM
    Arch Microbiol; 2019 Oct; 201(8):1147-1149. PubMed ID: 31147748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliable differentiation of Meyerozyma guilliermondii from Meyerozyma caribbica by internal transcribed spacer restriction fingerprinting.
    Romi W; Keisam S; Ahmed G; Jeyaram K
    BMC Microbiol; 2014 Feb; 14():52. PubMed ID: 24575831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3-year study of
    Sharifi M; Badiee P; Abastabar M; Morovati H; Haghani I; Noorbakhsh M; Mohammadi R
    Front Cell Infect Microbiol; 2023; 13():1152552. PubMed ID: 37249981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological characterization and molecular identification of some rare yeast species causing onychomycosis.
    Montoya AM; Luna-Rodríguez CE; Bonifaz A; Treviño-Rangel RJ; Rojas OC; González GM
    J Mycol Med; 2021 Jun; 31(2):101121. PubMed ID: 33626414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibility profile of invasive
    Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
    J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
    Cuenca-Estrella M; Mellado E; Díaz-Guerra TM; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
    Espinel-Ingroff A; Sasso M; Turnidge J; Arendrup M; Botterel F; Bourgeois N; Bouteille B; Canton E; Cassaing S; Dannaoui E; Dehais M; Delhaes L; Dupont D; Fekkar A; Fuller J; Garcia-Effron G; Garcia J; Gonzalez GM; Govender NP; Guegan H; Guinea J; Houzé S; Lass-Flörl C; Pelaez T; Forastiero A; Lackner M; Magobo R
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0109321. PubMed ID: 34370582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?].
    Turan D; Aksaray S
    Mikrobiyol Bul; 2022 Jul; 56(3):493-505. PubMed ID: 35960240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.